All hinges on AZ here. If AZ don't support this, rest of the pharma business may have second thoughts. Good that 2 further large pharma companies want to test it though and pay for all the costs associated with that. They must think it worthwhile trialing, so that is positive. Next quarter will be significant
Ann: Strategy Update, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(3.03%) |
Mkt cap ! $25.08M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $24.18K | 1.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1728515 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 315000 | 3 |
View Market Depth
| Last trade - 10.33am 16/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |